General Information of the Cell Line
Cell Line ID
CL000584
Cell Line Name
RAW-Lucia ISG
Category
Cancer cell line
Organism
Mus musculus (Mouse)
Cellosaurus ID
CVCL_X596
Tissue Information
Ascites
Disease
Mouse leukemia (NCIt: C21604)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT04739, Cyclic GMP-AMP synthase
Compound ID Compound Name Compound Formula
CP0953224
3-(1-(6,7-dichloro-1H-benzo[d]imidazol-2-yl)-5-hydroxy-3-methyl-1H-pyrazol-4-yl)isobenzofuran-1(3H)-one
   Show/Hide
C19H12Cl2N4O3
 1
1
IC50 = 2120 nM
   TI
   LI
   LO
   TS
CP0579667
1,1,1,3,3,3-hexafluoropropan-2-yl 6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carboxylate
   Show/Hide
C19H14Cl2F6N4O2
 1
1
IC50 = 3230 nM
   TI
   LI
   LO
   TS
CP0564583
N-[2-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]-2-oxoethyl]-2,2-difluoro-2-(4-methylphenoxy)acetamide
   Show/Hide
C26H23Cl2F2N5O3
 1
1
IC50 = 6690 nM
   TI
   LI
   LO
   TS
CP0564586
N-[2-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]-2-oxoethyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide
   Show/Hide
C27H20Cl2F3N7O3
 1
1
IC50 = 7620 nM
   TI
   LI
   LO
   TS
CP0555277
N-[2-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]-2-oxoethyl]-2-(furan-2-yl)acetamide
   Show/Hide
C23H21Cl2N5O3
 1
1
IC50 = 7700 nM
   TI
   LI
   LO
   TS
CP0527945
[2-[9b-[3,5-bis(trifluoromethyl)anilino]-6,7-dichloro-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-2-oxoethyl] acetate
   Show/Hide
C23H17Cl2F6N3O3
 1
1
IC50 = 7940 nM
   TI
   LI
   LO
   TS
CP0947460
1-(6,7-Dichloro-9b-(1H-indol-3-yl)-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3-b]indol-2-yl)-2-hydroxyethan-1-one
   Show/Hide
C21H19Cl2N3O2
 1
1
IC50 = 8420 nM
   TI
   LI
   LO
   TS
CP0955082
2-(6,7-Dichloro-9b-(1H-indol-3-yl)-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3-b]indol-2-yl)-2-oxoethyl Acetate
   Show/Hide
C23H21Cl2N3O3
 1
1
IC50 = 8750 nM
   TI
   LI
   LO
   TS
CP0545588
[2-[6,7-dichloro-9b-[2-formyl-4-(trifluoromethyl)anilino]-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-2-oxoethyl] acetate
   Show/Hide
C23H18Cl2F3N3O4
 1
1
IC50 = 9010 nM
   TI
   LI
   LO
   TS
CP0573341
N-[2-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]-2-oxoethyl]-2-(5-methyl-1,2-oxazol-3-yl)acetamide
   Show/Hide
C23H22Cl2N6O3
 1
1
IC50 = 9200 nM
   TI
   LI
   LO
   TS
CP0527948
1-[9b-[3,5-bis(trifluoromethyl)anilino]-6,7-dichloro-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-2-hydroxyethanone
   Show/Hide
C21H15Cl2F6N3O2
 1
1
IC50 = 9560 nM
   TI
   LI
   LO
   TS
CP0967557
2-(6,7-Dichloro-9b-(1H-indol-3-yl)-1,3,4,9b-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)-2-oxoethyl Acetate
   Show/Hide
C23H19Cl2N3O3
 1
1
IC50 = 9730 nM
   TI
   LI
   LO
   TS
CP0549330
1-[6,7-dichloro-9b-[4-(trifluoromethyl)anilino]-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-2-hydroxyethanone
   Show/Hide
C20H16Cl2F3N3O2
 1
1
IC50 = 9940 nM
   TI
   LI
   LO
   TS
CP0564585
2-amino-1-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]ethanone
   Show/Hide
C17H17Cl2N5O
 1
1
IC50 = 10900 nM
   TI
   LI
   LO
   TS
CP0573339
[2-[6,7-dichloro-9b-(3-chloro-2-formylanilino)-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-2-oxoethyl] acetate
   Show/Hide
C22H18Cl3N3O4
 1
1
IC50 = 11100 nM
   TI
   LI
   LO
   TS
CP0527944
2-amino-N-[2-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]-2-oxoethyl]acetamide
   Show/Hide
C19H20Cl2N6O2
 1
1
IC50 = 11400 nM
   TI
   LI
   LO
   TS
CP0957294
1-(6,7-Dichloro-9b-(1H-indol-3-yl)-1,3,4,9b-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)-2-hydroxyethan-1-one
   Show/Hide
C21H17Cl2N3O2
 1
1
IC50 = 14200 nM
   TI
   LI
   LO
   TS
CP0549328
[2-[6,7-dichloro-9b-(4-chloro-2-formylanilino)-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-2-oxoethyl] acetate
   Show/Hide
C22H18Cl3N3O4
 1
1
IC50 = 16300 nM
   TI
   LI
   LO
   TS
CP0941170
(R)-N-(2-(6,7-Dichloro-9-(1-methyl-1H-pyrazol-3-yl)-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2 yl)-2-oxoethyl)-4,4-difluoropyrrolidine-2-carboxamide
   Show/Hide
C22H22Cl2F2N6O2
 1
1
IC50 = 17400 nM
   TI
   LI
   LO
   TS
CP0547099
1-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]-2-hydroxyethanone
   Show/Hide
C17H16Cl2N4O2
 1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0577822
1-(5,6-dichloro-11,14-dimethoxy-8,16,18-triazapentacyclo[7.7.4.01,9.02,7.010,15]icosa-2(7),3,5,10,12,14-hexaen-18-yl)-2-hydroxyethanone
   Show/Hide
C21H21Cl2N3O4
 1
1
IC50 = 20100 nM
   TI
   LI
   LO
   TS
CP0549843
1-[6,7-dichloro-9-(1-methylpyrazol-3-yl)-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl]-2-(methylamino)ethanone
   Show/Hide
C18H19Cl2N5O
 1
1
IC50 = 21900 nM
   TI
   LI
   LO
   TS
CP0954216
1-(6,7-Dichloro-9b-(6-chloro-1H-indol-3-yl)-1,3,4,9b-tetrahydro-2H-pyrido[4,3 b]indol-2-yl)-2-hydroxyethan-1-one
   Show/Hide
C21H16Cl3N3O2
 1
1
IC50 = 22000 nM
   TI
   LI
   LO
   TS
CP0564584
1-[6,7-dichloro-9b-(2-methoxyanilino)-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-2-hydroxyethanone
   Show/Hide
C20H19Cl2N3O3
 1
1
IC50 = 22800 nM
   TI
   LI
   LO
   TS
CP0527947
2-hydroxy-1-[(1R,9S,13R,14R)-5,6,17-trichloro-22-oxa-8,11,21-triazahexacyclo[12.7.1.01,9.02,7.09,13.015,20]docosa-2(7),3,5,15(20),16,18-hexaen-11-yl]ethanone
   Show/Hide
C20H16Cl3N3O3
 1
1
IC50 = 37600 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Ascites)
Cell Line Name Organism Disease
PEO1 Homo sapiens (Human) BRCA2-associated hereditary breast and ovarian cancer syndrome
MAST Homo sapiens (Human) Breast carcinoma
Ramos Homo sapiens (Human) Burkitt lymphoma
CA46 Homo sapiens (Human) Burkitt lymphoma
CellSensor STAT6-bla RA-1 Homo sapiens (Human) Burkitt lymphoma
NCI-H716 Homo sapiens (Human) Cecum adenocarcinoma
COLO 205 Homo sapiens (Human) Colon adenocarcinoma
COLO 201 Homo sapiens (Human) Colon adenocarcinoma
DiFi Homo sapiens (Human) Colorectal carcinoma
U-2932 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
DB Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
HEC-50B Homo sapiens (Human) Endometrial adenocarcinoma
SNU-5 Homo sapiens (Human) Gastric adenocarcinoma
SNU-16 Homo sapiens (Human) Gastric adenocarcinoma
SNU-620 Homo sapiens (Human) Gastric adenocarcinoma
SNU-638 Homo sapiens (Human) Gastric adenocarcinoma
SNU-668 Homo sapiens (Human) Gastric signet ring cell adenocarcinoma
OVCAR-3 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
OVCAR-5 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
COV318 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
ZR-75-1 Homo sapiens (Human) Invasive breast carcinoma of no special type
SK-HEP-1 Homo sapiens (Human) Liver and intrahepatic bile duct epithelial neoplasm
OV-90 Homo sapiens (Human) Ovarian adenocarcinoma
LK2 Homo sapiens (Human) Ovarian carcinoma
RMG-I Homo sapiens (Human) Ovarian clear cell adenocarcinoma
PA-1 Homo sapiens (Human) Ovarian mixed germ cell tumor
SK-OV-3 Homo sapiens (Human) Ovarian serous cystadenocarcinoma
SKOV3/TR Homo sapiens (Human) Ovarian serous cystadenocarcinoma
AsPC-1 Homo sapiens (Human) Pancreatic ductal adenocarcinoma
HEC Homo sapiens (Human) Peritoneal malignant mesothelioma
Ehrlich-Lettre ascites strain E Mus musculus (Mouse) Malignant neoplasms of the mouse mammary gland
RAW 264.7 Mus musculus (Mouse) Mouse leukemia
L1210 Mus musculus (Mouse) Mouse leukemia
L1210/R81 Mus musculus (Mouse) Mouse leukemia
RAW-Lucia ISG-KO-STING Mus musculus (Mouse) Mouse leukemia
RAW 264 Mus musculus (Mouse) Mouse leukemia
J774 Mus musculus (Mouse) Mouse reticulum cell sarcoma
J774A1 Mus musculus (Mouse) Mouse reticulum cell sarcoma
HTC Rattus norvegicus (Rat) Rat hepatocellular carcinoma